01 10Creon
02 2Creon
03 1Zenpep
Main Therapeutic Indication : Rare Disorders
Currency : USD
2020 Revenue in Millions : 1,114
2019 Revenue in Millions : 1,041
Growth (%) : 7
Main Therapeutic Indication : Rare Disorders
Currency : USD
2021 Revenue in Millions : 1,191
2020 Revenue in Millions : 1,114
Growth (%) : 7
Main Therapeutic Indication : Rare Diseases
Currency : USD
2022 Revenue in Millions : 1,278
2021 Revenue in Millions : 1,191
Growth (%) : 7
Main Therapeutic Indication : Rare Disease
Currency : USD
2015 Revenue in Millions : 516
2014 Revenue in Millions : 632
Growth (%) : 22%
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 1,268
2022 Revenue in Millions : 1,278
Growth (%) : -1
Main Therapeutic Indication : Rare Diseases
Currency : USD
2017 Revenue in Millions : 831
2016 Revenue in Millions : 730
Growth (%) : 14
Main Therapeutic Indication : Rare Diseases
Currency : USD
2016 Revenue in Millions : 730
2015 Revenue in Millions : 632
Growth (%) : 16
Main Therapeutic Indication : Rare Diseases
Currency : USD
2018 Revenue in Millions : 928
2017 Revenue in Millions : 831
Growth (%) : 12%
Main Therapeutic Indication : Rare Disorders
Currency : USD
2019 Revenue in Millions : 1,041
2018 Revenue in Millions : 928
Growth (%) : 12
Main Therapeutic Indication : Rare Disease
Currency : USD
2014 Revenue in Millions : 25.20%
2013 Revenue in Millions :
Growth (%) :